Mylan Labs Proposed Merger with King Pharmaceutical Harvard Case Solution & Analysis

Perry Capital owns shares of the king and to facilitate the approval of the merger, to buy shares Mylan, while hedging their economic effects of Mylan's stock price using derivatives. The price at which Mylan proposes to merge with the king is generous to the king of shareholders, but the merger does not seem to be approved by shareholders of Mylan, which must vote on it. If Perry can swing the vote in favor of the deal, he will be nicely on its shares king without facing any corresponding loss Mylan holdings as those hedges. Carl Icahn, the other shareholder in Mylan, opposes the deal and sued Perry on charges of vote-buying. "Hide
by Lucy White Source: Harvard Business School 8 pages. Publication Date: January 14, 2009. Prod. #: 209097-PDF-ENG

Mylan Labs Proposed Merger with King Pharmaceutical Case Solution Other Similar Case Solutions like

Mylan Labs Proposed Merger with King Pharmaceutical

Share This